{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:57:36Z","timestamp":1790989056262,"version":"4.1.0"},"reference-count":122,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016979","name":"National Treasury","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016979","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015777","name":"Division of Research Capacity Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015777","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.bbadis.2026.168470","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:29:17Z","timestamp":1789774157000},"page":"168470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oxidative lipoprotein remodelling in atherogenesis: Mechanistic insights and therapeutic potential"],"prefix":"10.1016","volume":"1873","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2747-1841","authenticated-orcid":false,"given":"Sinenhlanhla X.H.","family":"Mthembu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phiwayinkosi V.","family":"Dludla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2026.168470_bb0005","author":"WHO. World Health Organization"},{"key":"10.1016\/j.bbadis.2026.168470_bb0010","doi-asserted-by":"crossref","DOI":"10.1177\/15598276251405214","article-title":"The impact of unhealthy lifestyle on the burden of non-communicable diseases in the State of Qatar: a systematic analysis of the global burden of disease study 2021","author":"Melaku","year":"2025","journal-title":"Am. J. Lifestyle Med."},{"issue":"9","key":"10.1016\/j.bbadis.2026.168470_bb0015","doi-asserted-by":"crossref","first-page":"e998","DOI":"10.1016\/S2214-109X(18)30275-4","article-title":"Prevalence of dyslipidaemia among adults in Africa: a systematic review and meta-analysis","volume":"6","author":"Noubiap","year":"2018","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.bbadis.2026.168470_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.778891","article-title":"Determinants of dyslipidemia in Africa: a systematic review and meta-analysis","volume":"8","author":"Obsa","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.bbadis.2026.168470_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1008335","article-title":"Cardiovascular diseases in Africa in the twenty-first century: gaps and priorities going forward","volume":"9","author":"Minja","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"7","key":"10.1016\/j.bbadis.2026.168470_bb0030","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1161\/CIRCRESAHA.120.318729","article-title":"Hypertension in low- and middle-income countries","volume":"128","author":"Schutte","year":"2021","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.bbadis.2026.168470_bb0035","first-page":"95","article-title":"Hypertension in sub-Saharan Africa: the current profile, recent advances, gaps, and priorities","volume":"39","author":"Gafane-Matemane","year":"2025","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.bbadis.2026.168470_bb0040","article-title":"African regional and national burden of diabetes mellitus and its attributable risk factors from 1990 to 2021: results from the global burden of disease study 2021","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbadis.2026.168470_bb0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.biochi.2022.08.018","article-title":"Impact of dyslipidemia in the development of cardiovascular complications: delineating the potential therapeutic role of coenzyme Q(10)","volume":"204","author":"Mthembu","year":"2023","journal-title":"Biochimie"},{"issue":"2","key":"10.1016\/j.bbadis.2026.168470_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27021075","article-title":"Oxidative stress and its role in vascular damage and atherosclerosis","volume":"27","author":"Pozo Gir\u00e1ldez","year":"2026","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.bbadis.2026.168470_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11112897","article-title":"Oxidative stress, atherogenic dyslipidemia, and cardiovascular risk","volume":"11","author":"Vekic","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168470_bb0060","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s41043-025-01054-3","article-title":"Global prevalence of dyslipidemias in the general adult population: a systematic review and meta-analysis","volume":"44","author":"Ballena-Caicedo","year":"2025","journal-title":"J. Health Popul. Nutr."},{"issue":"10","key":"10.1016\/j.bbadis.2026.168470_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187347","article-title":"Awareness, treatment, and control of dyslipidemia in rural South Africa: the HAALSI (Health and Aging in Africa: A Longitudinal Study of an INDEPTH Community in South Africa) study","volume":"12","author":"Reiger","year":"2017","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.bbadis.2026.168470_bb0070","doi-asserted-by":"crossref","DOI":"10.7196\/SAMJ.2018.v108i4.13265","article-title":"Dyslipidaemia in South Africa","volume":"108","author":"Ntusi","year":"2018","journal-title":"S. Afr. Med. J."},{"key":"10.1016\/j.bbadis.2026.168470_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1389106","article-title":"Beyond LDL-C: unravelling the residual atherosclerotic cardiovascular disease risk landscape-focus on hypertriglyceridaemia","volume":"11","author":"Bashir","year":"2024","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.bbadis.2026.168470_bb0080","doi-asserted-by":"crossref","first-page":"29240","DOI":"10.3402\/fnr.v59.29240","article-title":"LDL biochemical modifications: a link between atherosclerosis and aging","volume":"59","author":"Alique","year":"2015","journal-title":"Food Nutr. Res."},{"issue":"6","key":"10.1016\/j.bbadis.2026.168470_bb0085","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3892\/mmr.2025.13693","article-title":"Small dense LDL: an underestimated driver of atherosclerosis (review)","volume":"32","author":"Bekbossynova","year":"2025","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbadis.2026.168470_bb0090","doi-asserted-by":"crossref","DOI":"10.34133\/bmr.0252","article-title":"Endothelial dysfunction in atherosclerosis: experimental models and therapeutics","volume":"29","author":"Kopych","year":"2025","journal-title":"Biomater. Res."},{"issue":"7534","key":"10.1016\/j.bbadis.2026.168470_bb0095","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature13997","article-title":"The African genome variation project shapes medical genetics in Africa","volume":"517","author":"Gurdasani","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2026.168470_bb0100","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2261-9-30","article-title":"Gender-related differences in the prevalence of cardiovascular disease risk factors and their correlates in urban Tanzania","volume":"9","author":"Njelekela","year":"2009","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.bbadis.2026.168470_bb0105","article-title":"Oxidized low-density lipoproteins and their contribution to atherosclerosis","volume":"3","author":"Babakr","year":"2025","journal-title":"Exploration of Cardiology"},{"issue":"5","key":"10.1016\/j.bbadis.2026.168470_bb0110","doi-asserted-by":"crossref","first-page":"569","DOI":"10.7150\/ijbs.14027","article-title":"Dysregulation of the low-density lipoprotein receptor pathway is involved in lipid disorder-mediated organ injury","volume":"12","author":"Zhang","year":"2016","journal-title":"Int. J. Biol. Sci."},{"issue":"23","key":"10.1016\/j.bbadis.2026.168470_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/cells11233843","article-title":"The role of oxidative stress in atherosclerosis","volume":"11","author":"Batty","year":"2022","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.bbadis.2026.168470_bb0120","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/bmm.11.60","article-title":"Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events","volume":"5","author":"Taleb","year":"2011","journal-title":"Biomark. Med."},{"key":"10.1016\/j.bbadis.2026.168470_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.redox.2017.11.017","article-title":"Oxidized LDL triggers changes in oxidative stress and inflammatory biomarkers in human macrophages","volume":"15","author":"Lara-Guzm\u00e1n","year":"2018","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168470_bb0130","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0021-9150(03)00280-6","article-title":"Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: the PRIME study","volume":"170","author":"Luc","year":"2003","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.bbadis.2026.168470_bb0135","doi-asserted-by":"crossref","first-page":"262","DOI":"10.14218\/JERP.2024.00020","article-title":"Antioxidant-enzyme interaction in non-communicable diseases","volume":"9","author":"Ezema","year":"2024","journal-title":"J. Explor. Res. Pharmacol."},{"issue":"10","key":"10.1016\/j.bbadis.2026.168470_bb0140","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1161\/CIRCRESAHA.111.243972","article-title":"Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system","volume":"110","author":"Lass\u00e8gue","year":"2012","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168470_bb0145","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-025-02591-w","article-title":"Cardiovascular disease risk factors are associated with conventional lipids and apolipoproteins in South African adults of African ancestry","volume":"24","author":"Vorster","year":"2025","journal-title":"Lipids Health Dis."},{"issue":"3","key":"10.1016\/j.bbadis.2026.168470_bb0150","doi-asserted-by":"crossref","first-page":"247","DOI":"10.12997\/jla.2025.14.3.247","article-title":"Triglycerides, triglyceride-rich lipoproteins, and remnant cholesterol in atherosclerotic cardiovascular disease","volume":"14","author":"Jo","year":"2025","journal-title":"J. Lipid Atheroscler."},{"issue":"9","key":"10.1016\/j.bbadis.2026.168470_bb0155","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1161\/ATVBAHA.111.241463","article-title":"Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia","volume":"32","author":"Sparks","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2026.168470_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.925923","article-title":"Mechanisms of oxidized LDL-mediated endothelial dysfunction and its consequences for the development of atherosclerosis","volume":"9","author":"Jiang","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"8","key":"10.1016\/j.bbadis.2026.168470_bb0165","article-title":"Oxidized LDLs as signaling molecules","volume":"10","author":"Zingg","year":"2021","journal-title":"Antioxidants (Basel)"},{"issue":"3","key":"10.1016\/j.bbadis.2026.168470_bb0170","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/MOL.0000000000000682","article-title":"Remnant lipoproteins: are they equal to or more atherogenic than LDL?","volume":"31","author":"Salinas","year":"2020","journal-title":"Curr. Opin. Lipidol."},{"issue":"8","key":"10.1016\/j.bbadis.2026.168470_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9080915","article-title":"Recognition of oxidized lipids by macrophages and its role in atherosclerosis development","volume":"9","author":"Mushenkova","year":"2021","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.bbadis.2026.168470_bb0180","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","article-title":"Immunity and inflammation in atherosclerosis","volume":"124","author":"Wolf","year":"2019","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.bbadis.2026.168470_bb0185","article-title":"Anti-oxidized LDL antibodies and coronary artery disease: a systematic review","volume":"8","author":"van den Berg","year":"2019","journal-title":"Antioxidants (Basel)"},{"issue":"5","key":"10.1016\/j.bbadis.2026.168470_bb0190","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1042\/BST20200602","article-title":"Role of the adaptive immune system in atherosclerosis","volume":"48","author":"Ley","year":"2020","journal-title":"Biochem. Soc. Trans."},{"issue":"11","key":"10.1016\/j.bbadis.2026.168470_bb0195","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1161\/ATVBAHA.123.319674","article-title":"Oxidized phospholipid oxPAPC induces a Th1-like phenotype in regulatory T cells and inhibits their protective function in atherosclerosis","volume":"43","author":"Appleton","year":"2023","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168470_bb0200","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tcm.2018.05.010","article-title":"Oxidized LDL and anti-oxidized LDL antibodies in atherosclerosis \u2013 novel insights and future directions in diagnosis and therapy","volume":"29","author":"Hartley","year":"2019","journal-title":"Trends Cardiovasc. Med."},{"issue":"5","key":"10.1016\/j.bbadis.2026.168470_bb0205","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jacc.2006.03.057","article-title":"Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?","volume":"48","author":"Wu","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.bbadis.2026.168470_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2026.100976","article-title":"Analytical validation of monoclonal antibody-based ELISA methods for OxPL-apoB and OxPL-apo(a)","volume":"67","author":"Marcovina","year":"2026","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2026.168470_bb0215","doi-asserted-by":"crossref","first-page":"8351","DOI":"10.3390\/ijms16048351","article-title":"Determination of oxidized phosphatidylcholines by hydrophilic interaction liquid chromatography coupled to Fourier transform mass spectrometry","volume":"16","author":"Sala","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bbadis.2026.168470_bb0220","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1373\/clinchem.2005.064337","article-title":"Analytical performance and diagnostic accuracy of immunometric assays for the measurement of circulating oxidized LDL","volume":"52","author":"Holvoet","year":"2006","journal-title":"Clin. Chem."},{"issue":"15","key":"10.1016\/j.bbadis.2026.168470_bb0225","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/01.CIR.98.15.1487","article-title":"Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease","volume":"98","author":"Holvoet","year":"1998","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.bbadis.2026.168470_bb0230","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1161\/01.ATV.21.5.844","article-title":"Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease","volume":"21","author":"Holvoet","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2026.168470_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1023651","article-title":"Oxidized low-density lipoprotein associates with cardiovascular disease by a vicious cycle of atherosclerosis and inflammation: a systematic review and meta-analysis","volume":"9","author":"Hong","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"issue":"14","key":"10.1016\/j.bbadis.2026.168470_bb0240","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18459","article-title":"OxLDL as a prognostic biomarker of plaque instability in patients qualified for carotid endarterectomy","volume":"28","author":"Wo\u017aniak","year":"2024","journal-title":"J. Cell. Mol. Med."},{"issue":"12","key":"10.1016\/j.bbadis.2026.168470_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/healthcare13121426","article-title":"Serum OxLDL levels are positively associated with the number of ischemic events and damaged blood vessels in patients with coronary artery disease","volume":"13","author":"Perez-Robles","year":"2025","journal-title":"Healthcare"},{"key":"10.1016\/j.bbadis.2026.168470_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2026.104118","article-title":"LDL oxidation and cerebrovascular aging: mechanisms of endothelial dysfunction, inflammation, and vascular cognitive impairment and dementia","volume":"92","author":"Ihuoma","year":"2026","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.bbadis.2026.168470_bb0255","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4239\/wjd.v6.i3.456","article-title":"Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus","volume":"6","author":"Tangvarasittichai","year":"2015","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.bbadis.2026.168470_bb0260","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/4136071","article-title":"The effect of bariatric surgery on circulating levels of oxidized low-density lipoproteins is apparently independent of changes in body mass index: a systematic review and meta-analysis","volume":"2021","author":"Jamialahmadi","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"5","key":"10.1016\/j.bbadis.2026.168470_bb0265","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.ajkd.2006.08.015","article-title":"Oxidative stress is progressively enhanced with advancing stages of CKD","volume":"48","author":"Dounousi","year":"2006","journal-title":"Am. J. Kidney Dis."},{"issue":"6","key":"10.1016\/j.bbadis.2026.168470_bb0270","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/00325481.2019.1643633","article-title":"Icosapent ethyl reduces atherogenic markers in high-risk statin-treated patients with stage 3 chronic kidney disease and high triglycerides","volume":"131","author":"Vijayaraghavan","year":"2019","journal-title":"Postgrad. Med."},{"issue":"3","key":"10.1016\/j.bbadis.2026.168470_bb0275","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/HCO.0000000000001286","article-title":"Genetic factors contributing to atherosclerosis","volume":"41","author":"Raddatz","year":"2026","journal-title":"Curr. Opin. Cardiol."},{"issue":"5","key":"10.1016\/j.bbadis.2026.168470_bb0280","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/MOL.0000000000000114","article-title":"PCSK9 and LDLR degradation: regulatory mechanisms in circulation and in cells","volume":"25","author":"Lagace","year":"2014","journal-title":"Curr. Opin. Lipidol."},{"issue":"2","key":"10.1016\/j.bbadis.2026.168470_bb0285","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.bbadis.2026.168470_bb0290","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng1509","article-title":"Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9","volume":"37","author":"Cohen","year":"2005","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168470_bb0295","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1038\/s41467-024-46336-2","article-title":"PCSK9 stimulates Syk, PKC\u03b4, and NF-\u03baB, leading to atherosclerosis progression independently of LDL receptor","volume":"15","author":"Shin","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2026.168470_bb0300","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2021.05.007","article-title":"APOE gene variants in primary dyslipidemia","volume":"328","author":"Khalil","year":"2021","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.bbadis.2026.168470_bb0305","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.116.001632","article-title":"PCSK9 loss-of-function variants, low-density lipoprotein cholesterol, and risk of coronary heart disease and stroke: data from 9 studies of blacks and whites","volume":"10","author":"Kent","year":"2017","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"3","key":"10.1016\/j.bbadis.2026.168470_bb0310","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/FPC.0b013e3282f44d99","article-title":"Molecular population genetics of PCSK9: a signature of recent positive selection","volume":"18","author":"Ding","year":"2008","journal-title":"Pharmacogenet. Genomics"},{"issue":"4","key":"10.1016\/j.bbadis.2026.168470_bb0315","first-page":"575","article-title":"High frequency of the apolipoprotein E *4 allele in African pygmies and most of the African populations in sub-Saharan Africa","volume":"69","author":"Zekraoui","year":"1997","journal-title":"Hum. Biol."},{"issue":"69_suppl","key":"10.1016\/j.bbadis.2026.168470_bb0320","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/14034950701355635","article-title":"Apolipoprotein E genotypes and their relation to lipid levels in a rural South African population 1","volume":"35","author":"Masemola","year":"2007","journal-title":"Scand. J. Public Health"},{"issue":"16","key":"10.1016\/j.bbadis.2026.168470_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/nu16162811","article-title":"LDL-cholesterol-lowering effects of a dietary supplement containing onion and garlic extract used in healthy volunteers","volume":"16","author":"Vezza","year":"2024","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.bbadis.2026.168470_bb0330","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jfda.2016.10.008","article-title":"Regulatory efficacy of fermented plant extract on the intestinal microflora and lipid profile in mildly hypercholesterolemic individuals","volume":"25","author":"Chiu","year":"2017","journal-title":"J. Food Drug Anal."},{"issue":"5","key":"10.1016\/j.bbadis.2026.168470_bb0335","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/CIRCULATIONAHA.122.059410","volume":"146","author":"Ridker","year":"2022","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.bbadis.2026.168470_bb0340","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1161\/ATVBAHA.116.308034","article-title":"Probucol in albuminuric type 2 diabetes mellitus patients on renin-angiotensin system blockade: a 16-week, randomized, double-blind, placebo-controlled trial","volume":"36","author":"Jin","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2026.168470_bb0345","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.clinbiochem.2018.10.007","article-title":"Weight loss achieved by bariatric surgery modifies high-density lipoprotein subfractions and low-density lipoprotein oxidation towards atheroprotection","volume":"63","author":"Coimbra","year":"2019","journal-title":"Clin. Biochem."},{"issue":"12","key":"10.1016\/j.bbadis.2026.168470_bb0350","doi-asserted-by":"crossref","DOI":"10.3390\/nu17122008","article-title":"An adapted cardioprotective diet with or without phytosterol and\/or krill oil supplementation in familial hypercholesterolemia: results of a pilot randomized clinical trial","volume":"17","author":"de Abreu-Silva","year":"2025","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.bbadis.2026.168470_bb0355","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1194\/jlr.P068585","article-title":"Statin action enriches HDL3 in polyunsaturated phospholipids and plasmalogens and reduces LDL-derived phospholipid hydroperoxides in atherogenic mixed dyslipidemia","volume":"57","author":"Orsoni","year":"2016","journal-title":"J. Lipid Res."},{"issue":"Pt 2","key":"10.1016\/j.bbadis.2026.168470_bb0360","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.foodres.2017.03.003","article-title":"Additional consumption of one egg per day increases serum lutein plus zeaxanthin concentration and lowers oxidized low-density lipoprotein in moderately hypercholesterolemic males","volume":"99","author":"Kishimoto","year":"2017","journal-title":"Food Res. Int."},{"issue":"5","key":"10.1016\/j.bbadis.2026.168470_bb0365","article-title":"Lipid oxidation products and the risk of cardiovascular diseases: role of lipoprotein transport","volume":"13","author":"Ahotupa","year":"2024","journal-title":"Antioxidants (Basel)"},{"issue":"2","key":"10.1016\/j.bbadis.2026.168470_bb0370","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00392-025-02833-y","article-title":"A practical guide to the management of dyslipidaemia","volume":"115","author":"Siegel","year":"2026","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.bbadis.2026.168470_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105499","article-title":"Optimal use of lipid-lowering therapy after acute coronary syndromes: a position paper endorsed by the International Lipid Expert Panel (ILEP)","volume":"166","author":"Banach","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"7","key":"10.1016\/j.bbadis.2026.168470_bb0380","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/clc.22687","article-title":"A phase 1 study to evaluate the safety and LDL cholesterol-lowering effects of RG7652, a fully human monoclonal antibody against proprotein convertase subtilisin\/kexin type 9","volume":"40","author":"Baruch","year":"2017","journal-title":"Clin. Cardiol."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168470_bb0385","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12944-018-0909-z","article-title":"Comparison of statin plus ezetimibe with double-dose statin on lipid profiles and inflammation markers","volume":"17","author":"Wu","year":"2018","journal-title":"Lipids Health Dis."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168470_bb0390","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1186\/s12944-024-02398-1","article-title":"Effects of Probucol on plasma amyloid-beta transport in patients with hyperlipidemia: a 12-week randomized, double-blind, placebo-controlled trial","volume":"23","author":"Dang","year":"2024","journal-title":"Lipids Health Dis."},{"issue":"4","key":"10.1016\/j.bbadis.2026.168470_bb0395","doi-asserted-by":"crossref","DOI":"10.3390\/biochem5040035","article-title":"Therapeutic strategies targeting oxidative stress and inflammation: a narrative review","volume":"5","author":"Manful","year":"2025","journal-title":"BioChem"},{"issue":"5","key":"10.1016\/j.bbadis.2026.168470_bb0400","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.amjcard.2019.05.057","article-title":"Effects of Icosapent ethyl (eicosapentaenoic acid ethyl ester) on atherogenic lipid\/lipoprotein, apolipoprotein, and inflammatory parameters in patients with elevated high-sensitivity C-reactive protein (from the ANCHOR study)","volume":"124","author":"Miller","year":"2019","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.bbadis.2026.168470_bb0405","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5478708","article-title":"Oxidative stress in the pathophysiology of kidney disease: implications for noninvasive monitoring and identification of biomarkers","volume":"2020","author":"Gyur\u00e1szov\u00e1","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"6","key":"10.1016\/j.bbadis.2026.168470_bb0410","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1253\/circj.CJ-18-0764","article-title":"Long-term comparison of ethyl Icosapentate vs. omega-3-acid ethyl in patients with cardiovascular disease and hypertriglyceridemia (DEFAT trial)","volume":"83","author":"Sezai","year":"2019","journal-title":"Circ. J."},{"key":"10.1016\/j.bbadis.2026.168470_bb0415","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7432797","article-title":"Oxidative stress and inflammation: what polyphenols can do for us?","volume":"2016","author":"Hussain","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"11","key":"10.1016\/j.bbadis.2026.168470_bb0420","doi-asserted-by":"crossref","DOI":"10.3390\/foods10112666","article-title":"Bioactivity of dietary polyphenols: the role in LDL-C lowering","volume":"10","author":"Sun","year":"2021","journal-title":"Foods"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168470_bb0425","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12944-020-01338-z","article-title":"The cholesterol-lowering effect of unripe Rubus coreanus is associated with decreased oxidized LDL and apolipoprotein B levels in subjects with borderline-high cholesterol levels: a randomized controlled trial","volume":"19","author":"Cho","year":"2020","journal-title":"Lipids Health Dis."},{"issue":"7","key":"10.1016\/j.bbadis.2026.168470_bb0430","doi-asserted-by":"crossref","DOI":"10.3390\/nu10070924","article-title":"\u201cBenifuuki\u201d extract reduces serum levels of lectin-like oxidized low-density lipoprotein receptor-1 ligands containing apolipoprotein B: a double-blind placebo-controlled randomized trial","volume":"10","author":"Miyawaki","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.bbadis.2026.168470_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106821","article-title":"Chios mastiha essential oil exhibits antihypertensive, hypolipidemic and anti-obesity effects in metabolically unhealthy adults - a randomized controlled trial","volume":"194","author":"Gioxari","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.bbadis.2026.168470_bb0440","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s11883-013-0324-x","article-title":"Polyphenols, inflammation, and cardiovascular disease","volume":"15","author":"Tangney","year":"2013","journal-title":"Curr. Atheroscler. Rep."},{"issue":"4","key":"10.1016\/j.bbadis.2026.168470_bb0445","doi-asserted-by":"crossref","DOI":"10.3390\/nu12041098","article-title":"Ubiquinol ameliorates endothelial dysfunction in subjects with mild-to-moderate dyslipidemia: a randomized clinical trial","volume":"12","author":"Sabbatinelli","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.bbadis.2026.168470_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2022.111703","article-title":"Coenzyme Q10 supplementation improves cholesterol efflux capacity and antiinflammatory properties of high-density lipoprotein in Chinese adults with dyslipidemia","volume":"101","author":"Zou","year":"2022","journal-title":"Nutrition"},{"issue":"Suppl","key":"10.1016\/j.bbadis.2026.168470_bb0455","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.mito.2007.03.003","article-title":"Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations","volume":"7","author":"Bhagavan","year":"2007","journal-title":"Mitochondrion"},{"issue":"2","key":"10.1016\/j.bbadis.2026.168470_bb0460","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera Amit","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.bbadis.2026.168470_bb0465","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1089\/ars.2018.7674","article-title":"The role of NADPH oxidases in the etiology of obesity and metabolic syndrome: contribution of individual isoforms and cell biology","volume":"31","author":"DeVallance","year":"2019","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbadis.2026.168470_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.119177","article-title":"The effects of a novel nutraceutical combination on low-density lipoprotein cholesterol and other markers of cardiometabolic health in adults with hypercholesterolaemia: a randomised double-blind placebo-controlled trial","volume":"403","author":"Stonehouse","year":"2025","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168470_bb0475","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2478\/enr-2024-0026","article-title":"Various apolipoprotein E genotypes relate to responsiveness to flaxseed lignan complex in older persons with type 2 diabetes mellitus","volume":"58","author":"Barre","year":"2024","journal-title":"Endocr. Regul."},{"issue":"9","key":"10.1016\/j.bbadis.2026.168470_bb0480","doi-asserted-by":"crossref","DOI":"10.3390\/nu14091925","article-title":"Variability in the beneficial effects of phenolic compounds: a review","volume":"14","author":"Eseberri","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.bbadis.2026.168470_bb0485","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.aninu.2023.05.012","article-title":"Carotenoid enrichment in eggs: from biochemistry perspective","volume":"14","author":"Dansou","year":"2023","journal-title":"Anim. Nutr."},{"key":"10.1016\/j.bbadis.2026.168470_bb0490","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jnutbio.2018.03.012","article-title":"Effect of short-term hazelnut consumption on DNA damage and oxidized LDL in children and adolescents with primary hyperlipidemia: a randomized controlled trial","volume":"57","author":"Guaraldi","year":"2018","journal-title":"J. Nutr. Biochem."},{"issue":"9","key":"10.1016\/j.bbadis.2026.168470_bb0495","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1089\/acm.2016.0414","article-title":"Clinoptilolite for treatment of dyslipidemia: preliminary efficacy study","volume":"23","author":"Cutovic","year":"2017","journal-title":"J. Altern. Complement. Med."},{"issue":"10384","key":"10.1016\/j.bbadis.2026.168470_bb0500","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","article-title":"Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials","volume":"401","author":"Ridker","year":"2023","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.bbadis.2026.168470_bb0505","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113499","article-title":"Atherogenic lipoproteins for the statin residual cardiovascular disease risk","volume":"23","author":"Yanai","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2026.168470_bb0510","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1308173","article-title":"Intermediate and long-term residual cardiovascular risk in patients with established cardiovascular disease treated with statins","volume":"10","author":"Vijayaraghavan","year":"2024","journal-title":"Front. Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168470_bb0515","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","article-title":"Pleiotropic effects of statins on the cardiovascular system","volume":"120","author":"Oesterle","year":"2017","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.bbadis.2026.168470_bb0520","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1194\/jlr.M003566","article-title":"Strong induction of PCSK9 gene expression through HNF1alpha and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters","volume":"51","author":"Dong","year":"2010","journal-title":"J. Lipid Res."},{"issue":"10","key":"10.1016\/j.bbadis.2026.168470_bb0525","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.amjcard.2017.02.020","article-title":"Effects of RG7652, a monoclonal antibody against PCSK9, on LDL-C, LDL-C subfractions, and inflammatory biomarkers in patients at high risk of or with established coronary heart disease (from the phase 2 EQUATOR study)","volume":"119","author":"Baruch","year":"2017","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.bbadis.2026.168470_bb0530","first-page":"415","article-title":"Ezetimibe therapy: mechanism of action and clinical update","volume":"8","author":"Phan","year":"2012","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.bbadis.2026.168470_bb0535","doi-asserted-by":"crossref","DOI":"10.7573\/dic.212534","article-title":"Adding ezetimibe to statin therapy: latest evidence and clinical implications","volume":"7","author":"Vavlukis","year":"2018","journal-title":"Drugs Context"},{"issue":"8","key":"10.1016\/j.bbadis.2026.168470_bb0540","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1080\/13543784.2020.1778668","article-title":"Bempedoic acid, an inhibitor of ATP citrate lyase for the treatment of hypercholesterolemia: early indications and potential","volume":"29","author":"Brandts","year":"2020","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.bbadis.2026.168470_bb0545","series-title":"Endotext","article-title":"Cholesterol lowering drugs","author":"Feingold","year":"2000"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168470_bb0550","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/phar.4635","article-title":"Current and emerging PCSK9-directed therapies to reduce LDL-C and ASCVD risk: a state-of-the-art review","volume":"45","author":"Garwood","year":"2025","journal-title":"Pharmacotherapy"},{"issue":"11","key":"10.1016\/j.bbadis.2026.168470_bb0555","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.70174","article-title":"PCSK9 inhibitors: the evolving future","volume":"7","author":"Jeswani","year":"2024","journal-title":"Health Sci. Rep."},{"key":"10.1016\/j.bbadis.2026.168470_bb0560","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cca.2012.08.021","article-title":"Oxidized high-density lipoprotein is associated with increased plasma glucose in non-diabetic dyslipidemic subjects","volume":"414","author":"Kotani","year":"2012","journal-title":"Clin. Chim. Acta"},{"issue":"Suppl_1","key":"10.1016\/j.bbadis.2026.168470_bb0565","doi-asserted-by":"crossref","DOI":"10.1161\/circ.150.suppl_1.4139206","article-title":"Abstract 4139206: design of Heart-2: a phase 1b clinical trial of VERVE-102, an in vivo base editing medicine delivered by a GalNAc-LNP and targeting PCSK9 to durably lower LDL cholesterol","volume":"150","author":"Vafai","year":"2024","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168470_bb0570","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12872-026-05515-3","article-title":"Inclisiran SiRNA therapy for durable LDL-C reduction: a systematic review and meta-analysis highlighting a breakthrough in long-term cardiovascular risk management","volume":"26","author":"Satyam","year":"2026","journal-title":"BMC Cardiovasc. Disord."},{"issue":"25","key":"10.1016\/j.bbadis.2026.168470_bb0575","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.bbadis.2026.168470_bb0580","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1161\/CIRCULATIONAHA.109.914820","article-title":"Pharmacogenomics: the genetics of variable drug responses","volume":"123","author":"Roden","year":"2011","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.bbadis.2026.168470_bb0585","doi-asserted-by":"crossref","DOI":"10.31083\/RCM47152","article-title":"The lipoprotein(a) implementation gap: bridging evidence and clinical practice","volume":"27","author":"Yang","year":"2026","journal-title":"Rev. Cardiovasc. Med."},{"key":"10.1016\/j.bbadis.2026.168470_bb0590","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.atherosclerosis.2022.04.005","article-title":"Lipoprotein(a) and ethnicities","volume":"349","author":"Mehta","year":"2022","journal-title":"Atherosclerosis"},{"issue":"17","key":"10.1016\/j.bbadis.2026.168470_bb0595","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020158","article-title":"Lp(a)-associated oxidized phospholipids in healthy black and white participants in relation to apo(a) size, age, and family structure","volume":"10","author":"Berglund","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168470_bb0600","doi-asserted-by":"crossref","DOI":"10.1007\/s12170-025-00759-8","article-title":"Current clinical trials for treating elevated lipoprotein(a)","volume":"19","author":"De Los Reyes","year":"2025","journal-title":"Curr. Cardiovasc. Risk Rep."},{"issue":"10","key":"10.1016\/j.bbadis.2026.168470_bb0605","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s11883-023-01141-y","article-title":"Treatment of Lp(a): is it the future or are we ready today?","volume":"25","author":"Tselepis","year":"2023","journal-title":"Curr. Atheroscler. Rep."},{"issue":"7","key":"10.1016\/j.bbadis.2026.168470_bb0610","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1161\/ATVBAHA.124.319483","article-title":"Lipoprotein(a) in the year 2024: a look back and a look ahead","volume":"44","author":"Tsimikas","year":"2024","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926003364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926003364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:24:22Z","timestamp":1790987062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443926003364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":122,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2027,1]]}},"alternative-id":["S0925443926003364"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168470","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxidative lipoprotein remodelling in atherogenesis: Mechanistic insights and therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168470","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"168470"}}